Association of IgG immunoglobulin and subclasses level with the severity of chromoblastomycosis due to Fonsecaea pedrosoi and therapeutic response to …
CMP e Silva de Azevedo, O Bruna-Romero… - European journal of …, 2014 - Springer
Chromoblastomycosis (CBM) is a chronic, suppurative, granulomatous mycosis of the skin
and subcutaneous tissues. The aim of this study was to evaluate the association between …
and subcutaneous tissues. The aim of this study was to evaluate the association between …
Humoral immune response in chromoblastomycosis during and after therapy
P Esterre, M Jahevitra… - Clinical Diagnostic …, 2000 - Am Soc Microbiol
ABSTRACT A longitudinal study was carried out in Madagascar, the most important focus of
chromoblastomycosis (P. Esterre, A. Andriantsimahavandy, E. Ramarcel, and JL Pecarrere …
chromoblastomycosis (P. Esterre, A. Andriantsimahavandy, E. Ramarcel, and JL Pecarrere …
The cell-mediated immune reaction in the cutaneous lesion of chromoblastomycosis and their correlation with different clinical forms of the disease
S Corrêa Garcia Pires d'Ávila, C Pagliari… - Mycopathologia, 2003 - Springer
Chromoblastomycosis is a fungal infection caused by dematiaceous fungi inducing skin
lesions of difficult treatment and of frequent recurrence. The objective of the present …
lesions of difficult treatment and of frequent recurrence. The objective of the present …
Immunoprecipitation techniques and ELISA in the detection of anti-Fonsecaea pedrosoi antibodies in chromoblastomycosis
MSM Vidal, LGM Castro, SC Cavalecate… - Revista do Instituto de …, 2003 - SciELO Brasil
Chromoblastomycosis (CBM) is a chronic subcutaneous infection caused by several
dematiaceous fungi. The most commonly etiological agent found in Brazil is Fonsecaea …
dematiaceous fungi. The most commonly etiological agent found in Brazil is Fonsecaea …
ITRACONAZOLE IN THE TREAMENT OF CHROMOBLASTOMYCOSIS DUE TO FONSECAEA PEDROSOI
F QUEIROZ‐TELLES, KS PURIM… - International journal …, 1992 - Wiley Online Library
The efficacy and tolerability of itraconazole in chromoblastomycosis due to Fonsecaea
pedrosoi were evaluated in a non‐comparative open clinical trial in 19 Brazilian patients …
pedrosoi were evaluated in a non‐comparative open clinical trial in 19 Brazilian patients …
[HTML][HTML] Clinical aspects of previously treated chromoblastomycosis: a case series from Madagascar
FA Sendrasoa, NH Razanakoto… - International Journal of …, 2020 - Elsevier
Objective To describe the clinical aspects of chromoblastomycosis (CBM) presented by
patients who had received incomplete antifungal treatment before consultation. Methods A …
patients who had received incomplete antifungal treatment before consultation. Methods A …
[HTML][HTML] Cytokines and lymphocyte proliferation in patients with different clinical forms of chromoblastomycosis
Chromoblastomycosis is a chronic, often debilitating, suppurative, granulomatus mycosis of
the skin and subcutaneous tissues beginning after inoculation trauma. It occurs world-wide …
the skin and subcutaneous tissues beginning after inoculation trauma. It occurs world-wide …
A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi Successfully Treated by Oral Itraconazole Together with Terbinafine
XC Shen, XN Dai, ZM Xie, P Li, S Lu, JH Li… - Dermatology and …, 2020 - Springer
Patients with chromoblastomycosis (CBM) usually have a history of local skin damage
related to outdoor activities, mainly manifested as chronic refractory proliferative pathologic …
related to outdoor activities, mainly manifested as chronic refractory proliferative pathologic …
Reviewing the Etiologic Agents, Microbe‐Host Relationship, Immune Response, Diagnosis, and Treatment in Chromoblastomycosis
LFD Passero, IN Cavallone… - Journal of immunology …, 2021 - Wiley Online Library
Chromoblastomycosis (CBM) is a neglected human disease, caused by different species of
pigmented dematiaceous fungi that cause subcutaneous infections. This disease has been …
pigmented dematiaceous fungi that cause subcutaneous infections. This disease has been …
Cellular immune response of patients with chromoblastomycosis undergoing antifungal therapy
One of the most characteristic features of the chromoblastomycosis is its unresponsiveness
to treatment. In order to analyzed whether during therapy could be observed a change of …
to treatment. In order to analyzed whether during therapy could be observed a change of …